Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis

References

• Miller, H., D. J. Newell, and A. Ridley. 1961. Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.). Lancet. 2: 1120–1122
   PubMed Web of Science ®Google Scholar
• Rose, A. S., J. W. Kuzma, J. F. Kurtzke, et al. 1970. Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo – final report. Neurology 20: 1–59
   PubMed Web of Science ®Google Scholar
• Thompson, A. J., C. Kennard, M. Swash, B. Summers, et al. 1989. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology. 39: 969–971
   Google Scholar
• Catania, A., S. Gatti, G. Colombo, and J. M. Lipton. 2004. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56: 1–29
   PubMed Web of Science ®Google Scholar
• Arnason, B. G., R. Berkovich, A. Catania, et al. 2013. Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult. Scler. 19: 130–136
   PubMed Web of Science ®Google Scholar
• Libbey, J. E., I. Tsunoda, and R. S. Fujinami. 2010. Studies in the modulation of experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 5: 168–175
   PubMedGoogle Scholar
• Tsunoda, I., and R. S. Fujinami. 1996. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler’s murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55: 673–686
   PubMed Web of Science ®Google Scholar
• Libbey, J. E., and R. S. Fujinami. 2011. Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine 29: 3356–3362
   Google Scholar
• Steinman, L., and S. S. Zamvil. 2006. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60: 12–21
   PubMed Web of Science ®Google Scholar
• Field, E. J., and H. Miller. 1961. Studies in the inhibition of experimental allergic encephalomyelitis. Arch. Int. Pharmacodyn. Ther. 134: 76–88
   Google Scholar
• Moyer, A. W., G. A. Jervis, J. Black, et al. 1950. Action of adrenocorticotropic hormone (ACTH) in experimental allergic encephalomyelitis of the guinea pig. Proc. Soc. Exp. Biol. Med. 75: 387–390
   Google Scholar
• Brod, S. A., and Z. M. Hood. 2011. Ingested (oral) ACTH inhibits EAE. J. Neuroimmunol. 232: 131–135
   Google Scholar
• Brod, S. A., and Z. M. Hood. 2008. Ingested (oral) alpha-MSH inhibits acute EAE. J. Neuroimmunol. 193: 106–112
   Google Scholar
• Tuohy, V. K., Z. Lu, R. A. Sobel, et al. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523–1527
   PubMed Web of Science ®Google Scholar
• Ahmed, R. 1992. Immunological memory against viruses. Semin. Immunol. 4: 105–109
   Google Scholar
• Cusick, M. F., J. E. Libbey, N. S. Trede, et al. 2012. Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen. J. Neuroimmunol. 244: 35–44
   Google Scholar
• Decker, D., C. Grant, L. Oh, et al. 2014. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus. Lupus 23: 802–812
   PubMed Web of Science ®Google Scholar
• Kirkman, N. J., J. E. Libbey, K. S. Wilcox, et al. 2010. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 51: 454–464
   Google Scholar
• Trede, N. S., W. Heaton, S. Ridges, et al. 2013. Discovery of biologically active oncologic and immunologic small molecule therapies using zebrafish: overview and example of modulation of T cell activation. Curr. Protoc. Pharmacol. Chapter 14, Unit14.24
   Google Scholar
• Nair, A., T. J. Frederick, and S. D. Miller. 2008. Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 65: 2702–2720
   PubMed Web of Science ®Google Scholar
• Eng, L. F. 1985. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8: 203–214
   PubMed Web of Science ®Google Scholar
• Cusick, M. F., J. E. Libbey, D. C. Patel, et al. 2013. Infiltrating macrophages are key to the development of seizures following virus infection. J. Virol. 87: 1849–1860
   Google Scholar
• Delgado, R., A. Carlin, L. Airaghi, et al. 1998. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukoc. Biol. 63: 740–745
   PubMed Web of Science ®Google Scholar
• Taylor, A. W., and K. Namba. 2001. In vitro induction of CD25+CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol. Cell. Biol. 79: 358–367
   PubMed Web of Science ®Google Scholar
• Besser, G. M., P. W. Butler, and F. S. Plumpton. 1967. Adrenocorticotrophic action of long – acting tretracosactrin compared with corticotrophin-gel. Br. Med. J. 4: 391–394
   PubMed Web of Science ®Google Scholar
• Coburg, A. J., S. H. Gray, F. H. Katz, et al. 1970. Disappearing rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings. Surg. Gynecol. Obstet. 131: 933–942
   PubMedGoogle Scholar
• Taylor, A. W., and N. Kitaichi. 2008. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy. Brain Behav. Immun. 22: 639–646
   PubMed Web of Science ®Google Scholar
• Beers, D. R., J. S. Henkel, Q. Xiao, et al. 2006. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 103: 16021–16026
   PubMed Web of Science ®Google Scholar
• Ginhoux, F., M. Greter, M. Leboeuf, et al. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841–845
   PubMed Web of Science ®Google Scholar
• McKercher, S. R., B. E. Torbett, K. L. Anderson, et al. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15: 5647–5658
   PubMed Web of Science ®Google Scholar
• Ponomarev, E. D., L. P. Shriver, K. Maresz, and B. N. Dittel. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci. Res. 81: 374–389
   PubMed Web of Science ®Google Scholar
• Ford, A. L., A. L. Goodsall, W. F. Hickey, and J. D. Sedgwick. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 154: 4309–4321
   PubMed Web of Science ®Google Scholar
• Sedgwick, J. D., S. Schwender, H. Imrich, et al. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U.S.A. 88: 7438–7442
   PubMedGoogle Scholar